Chemed Reports Third-Quarter 2026 Revenue of $690.9 Million, EPS of $5.45
Revenue rose 10.6% year over year to $690.9 million, net income increased 11.5% to $71.6 million, and diluted EPS advanced 22.2% to $5.45. VITAS and Roto-Rooter growth contributed to the results.